Healthlink Diagnostic Laboratories, INC.

Healthlink Diagnostic Laboratories, INC. was paid $2.47M by Medicaid between Jan 2018 and Dec 2024, across 78 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 68% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#26 of 225

Median peer was paid$74K

This provider vs. median34×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	16,001	$43K
2019	35,132	$40K
2020	78,254	$573K
2021	182,168	$1.30M
2022	124,631	$395K
2023	103,369	$83K
2024incomplete	110,451	$31K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	68%	100,098	22,414	$1.69M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	14%	17,543	3,812	$342K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.1%	42,303	12,493	$77K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.5%	10,720	8,066	$63K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	2.2%	32,214	7,417	$55K
80053	Comprehensive metabolic panel	1.6%	48,854	27,535	$39K
84443	Thyroid stimulating hormone (TSH)	1.1%	19,424	13,824	$27K
80061	Lipid panel	1.1%	17,664	12,943	$26K
82607		<1%	10,375	7,761	$22K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	63,493	33,072	$17K
83036	Hemoglobin; glycosylated (A1C)	<1%	16,238	11,582	$17K
82746		<1%	6,876	5,419	$14K

66 more codes

84481		<1%	2,963	$11K
84439		<1%	8,532	$11K
80048	Basic metabolic panel (calcium, ionized)	<1%	17,928	$9K
87186		<1%	8,793	$7K
80164		<1%	5,174	$7K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,376	$4K
83880		<1%	1,780	$4K
87086	Culture, bacterial; quantitative colony count, urine	<1%	12,235	$3K
82140		<1%	3,124	$3K
84153		<1%	1,171	$3K
36415	Collection of venous blood by venipuncture	<1%	51,837	$2K
80177		<1%	2,033	$2K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	69,972	$2K
87088		<1%	9,297	$1K
82728		<1%	2,367	$1K
84134		<1%	1,221	$1K
85610		<1%	6,717	$1K
81003		<1%	7,499	$723.11
86803		<1%	51	$700.94
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	126	$687.01
83735		<1%	6,676	$576.64
86140		<1%	861	$498.69
83550		<1%	1,863	$445.21
83540		<1%	2,663	$427.11
81001		<1%	6,517	$389.74
86592		<1%	59	$243.58
85651		<1%	1,491	$217.87
86705		<1%	13	$169.29
86709		<1%	14	$161.92
84480		<1%	173	$141.62
84402		<1%	39	$126.88
84550		<1%	386	$123.97
80076		<1%	631	$114.09
82043		<1%	235	$110.30
85014		<1%	653	$109.29
87500		<1%	73	$104.40
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	203	$94.76
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	24,214	$85.51
87653		<1%	138	$74.56
87640		<1%	140	$74.56
80156		<1%	36	$65.64
87150		<1%	106	$58.68
84146		<1%	30	$56.88
87481		<1%	141	$44.88
84436		<1%	659	$40.49
80069		<1%	286	$39.89
86141		<1%	54	$26.29
86800		<1%	21	$11.66
82962		<1%	78	$9.76
86376		<1%	22	$8.73
84100		<1%	130	$5.09
85018		<1%	707	$4.92
87631		<1%	36	$3.82
82040		<1%	18	$2.57
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	0%	70	$0.00
82565		0%	74	$0.00
83721		0%	13	$0.00
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	0%	190	$0.00
82248		0%	72	$0.00
84520		0%	77	$0.00
82310		0%	27	$0.00
82570		0%	20	$0.00
87581		0%	30	$0.00
80185		0%	21	$0.00
87486		0%	31	$0.00
87493		0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialZAIDI, FARAH (OWNER)